Roche Group at ISTH 2024
Whether you have travelled for miles or just for a few minutes, we would like to welcome you to Bangkok.
We hope you enjoy this conference and take the time to discover more about our holistic innovation in bleeding disorders.
​
Please visit us at exhibition booth #1011 at the Queen Sirikit National Convention Centre and explore the different ways in which The Roche Group is helping present and future patients.
​
Join our upcoming activities sponsored by The Roche Group:
HEMLIBRA (Emicizumab) Clinical Management – Supporting People With Haemophilia A Throughout Their Lives
Sunday 23 June 2024
13:45 – 14:30 ICT
Join us to explore HEMLIBRA's benefits and optimise patient management across key clinical scenarios
Advancing the Standard of Care in Haemophilia A Prophylaxis: The Impact of HEMLIBRA (Emicizumab)
Tuesday 25 June 2024
13:45 – 14:30 ICT
​
Join our experts as we delve into the clinical and real-world data behind HEMLIBRA and its impact on haemophilia A management
SPARK Therapeutics: Taking a Closer Look: The Impact of Liver Health on Gene Therapy for Hemophilia A
Monday 24 June 2024
12:15 – 13:30 ICT
Join us for Spark Therapeutics’ symposium highlighting the impact of liver health on gene therapy for hemophilia A
Saturday 22 June 2024
13:00 – 14:15 ICT
Gene therapy - Clinical and pre-clinical
Oral Presentation highlighting The Roche Group data: Long Term Follow up of Participants in the Phase I/II Trial of Dirloctocogene Samoparvovec (SPK-8011): Durable FVIII Expression and Clinically Meaningful Reduction of Bleeding
Recordings only available to ISTH 2024 on-demand registrants
Recordings only available to ISTH 2024 on-demand registrants
M-XX-00016898 | Date of preparation: May 2024